Hydrapharm/AT Pharma - PharmaBoardroom

Last updated: 18.12.2018

Founded in 1995, Hyrapharm is a company under Algerian law oriented towards the distribution of pharmaceutical products.
Hyrapharm offers its partners an integrated services platform deploying all the trades of the value chain: direct and indirect distribution, import, medical information and manufacture of pharmaceutical products.
The acquisition of Walgreens Boots Alliance, the world leader in the sector, in the company’s capital in 2007 defines the Hyrapharm Group as an extension platform for the Maghreb and West Africa.
The Hyrapharm Group now has five pharmaceutical distribution subsidiaries, two import and distribution subsidiaries, one medical and marketing information subsidiary one parapharmaceutical brand, two products and regional sales outlets.

Related

Algerian Pharma & Healthcare: 5 Things to Know

With a healthcare system marked by both progress and difficulties due to the country’s economic overreliance on the oil and gas sector and its recent political instability, Algeria, is the…

Anthony Y. Lauw – GM & Head of Human Pharma Northwest Africa, Boehringer…

Dr Anthony Y. Lauw, GM & Head of Human Pharma Northwest Africa at Boehringer Ingelheim, explains the operations of a cluster that has typically worked with local partners, but that…

Middle East & Africa Pharma News Roundup September 2020

A roundup of the latest news from pharma in the Middle East and Africa including China’s announcement that it will be prioritising Africa for access to its COVID-19 vaccine, UAE…

The Case for an Algerian FDA in the Wake of Unethical TV Ads

In the wake of a spate of television advertisements for dietary supplements claiming to offer solutions to the COVID-19 crisis, regular PharmaBoardroom contributor Yacine Sellam argues for the need for…

Algeria Pharma News Roundup July 2020

Below we present recent news from Algeria’s pharmaceutical industry, including the creation of a dedicated Ministry to boost the sector, changes to the advertising rules for dietary supplements, and local…

Countering Algeria’s Diabetes Epidemic, With Pharmacists?

Yacine Sellam examines how pharmacists in Algeria can follow the lead of their US counterparts and play a greater role in patients’ diabetes management. Noncommunicable diseases are a growing…

European Solutions to Algeria’s Medicine Supply Shortages

Yacine Sellam, president of the Algerian Society for Regulatory Affairs & Pharmacoeconomics, looks at how European countries such as France and Belgium have countered medicine supply shortages and how Algeria…

Algeria’s Medicine Supply Shortage: Local Measures for a Global Problem

Yacine Sellam, president of the Algerian Society for Regulatory Affairs & Pharmacoeconomics, examines Algeria’s recent issues around medicine shortages, its root causes, and the measure being taken to counter it.…

MENA Pharma Market Set to Grow to USD 60 Billion

The Middle East and North Africa (MENA) region’s pharmaceutical market is projected to reach a value of around USD 60 billion by 2025 according to reporting from TradeArabia. The most…

Cancer Immunotherapy in Algeria: Between Therapeutic Progress and Budget…

Yacine Sellam, president of the Algerian Society for Regulatory Affairs & Pharmacoeconomics, outlines the progress made under Algeria’s National Cancer Plan and the steps that still need to be taken…

Adlane Soudani – General Manager, Ipsen Algeria

Adlane Soudani, general manager of Ipsen’s Algerian affiliate, lifts the lid on Ipsen’s ambitions for the local market, and the company’s parallel strategies to ramp up local production while simultaneously…

Guillaume Freneuil – Vice President Intercontinental Operations, Consumer…

Ipsen’s Guillaume Freneuil gives his take on the importance of the Algerian market to the global group. If we are investing right now in Algeria it is because we…